Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
Watashi
Koichi
K
Metselaar
Herold J
HJ
van der Laan
Luc J W
LJ
D000998:Antiviral Agents / Q000627:therapeutic use*; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use*; D016174:Hepacivirus / Q000187:drug effects*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007372:Interferons / Q000502:physiology; D012008:Recurrence; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D016559:Tacrolimus / Q000494:pharmacology / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D065095:Calcineurin Inhibitors; D016898:Interferon-alpha; D016572:Cyclosporine; D007372:Interferons; D016559:Tacrolimus